189157-31-1

Basic information

• Product Name: 3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin
• Synonyms: 3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin
• CAS NO: 189157-31-1
• Molecular Weight: 1053.21
• Mol File: 189157-31-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin(CAS DataBase Reference)
• NIST Chemistry Reference: 3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin(189157-31-1)
• EPA Substance Registry System: 3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin(189157-31-1)

Safety Data

• Hazardous Substances Data: 189157-31-1(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 51025-85-5 arbekacin 

Downstream Products

• 189157-32-2 4'',6''-O-cyclohexylidene-3,2',6',3'',4'''-pentakis(N-tert-butoxucarbonyl)arbekacin 

Relevant articles and documents

Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin

Arbekacin, an aminoglycoside antibiotic, is an important drug because it shows a potent efficacy against methicillin-resistant Staphylococcus aureus. However, resistance to arbekacin, which is caused mainly by the bifunctional aminoglycoside-modifying enz

NOVEL AMINOGLYCOSIDE ANTIBIOTIC EFFECTIVE AGAINST METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)

Disclosed are compounds represented by general formula (I) or pharmacologically acceptable salts or solvates thereof having excellent antimicrobial activity against bacteria causative of severe infections such as pneumonia and septicemia, particularly against MRSA, and also antimicrobial agents comprising these compounds, and pharmaceutical compositions comprising these compounds as an active component.